Lihua Sun
Biographic Data
| ID | 7297142 |
|---|---|
| NAME | Lihua Sun |
| GIVEN NAMES | Lihua |
| FAMILY NAME | Sun |
| SIGNATURE | SUN L |
| AFFILIATIONS | Chinese Academy of Medical Sciences & Peking Union Medical College |
| ORCID | 0000-0002-1660-623X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Analysis of nationwide availability of negotiated drugs in China’s National Reimbursement Drug List
Objective This study aims to evaluate the availability of Price-Negotiated Drugs under China’s National Reimbursement Drug List in healthcare institutions and designated retail pharmacies. Methods This cross-sectional study uses data from the National Health Insurance Service Platform (extracted in September 2025) to evaluate the availability of 383 National Negotiated Drugs in healthcare institutions and retail pharmacies nationwide. According t…
Drug supply and assurance: A cross-sectional study of drug shortage monitoring varieties in China
The situation of drug shortages in China was severe and complex, with serious shortages of medicines adapted to basic medical and healthcare needs and clinically necessary medicines, and a need to improve the production capacity of drugs and the ability to supply APIs. We recommend strengthening drug monitoring and stockpiling and accelerating the approval of shortage drugs to improve drug supply security
Kai Xin San aqueous extract improves Aβ 1-40 -induced cognitive deficits on adaptive behavior learning by enhancing memory-related molecules expression in the hippocampus
No prominent works on this page.
Kai Xin San aqueous extract improves Aβ 1-40 -induced cognitive deficits on adaptive behavior learning by enhancing memory-related molecules expression in the hippocampus
Drug supply and assurance: A cross-sectional study of drug shortage monitoring varieties in China
The situation of drug shortages in China was severe and complex, with serious shortages of medicines adapted to basic medical and healthcare needs and clinically necessary medicines, and a need to improve the production capacity of drugs and the ability to supply APIs. We recommend strengthening drug monitoring and stockpiling and accelerating the approval of shortage drugs to improve drug supply security
Analysis of nationwide availability of negotiated drugs in China’s National Reimbursement Drug List
Objective This study aims to evaluate the availability of Price-Negotiated Drugs under China’s National Reimbursement Drug List in healthcare institutions and designated retail pharmacies. Methods This cross-sectional study uses data from the National Health Insurance Service Platform (extracted in September 2025) to evaluate the availability of 383 National Negotiated Drugs in healthcare institutions and retail pharmacies nationwide. According t…
China (2 works) · Drug (2 works) · Medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Pharmacology (2 works) · Access to medicines (1 works) · Alzheimer's disease research and treatments (1 works) · Cognition (1 works) · Economic shortage (1 works) · Environmental health (1 works)